Last Updated on October 17, 2024 by The Health Master
Drug firm Alkem Laboratories yesterday said the US health regulator has conducted an inspection of its Taloja facility in Maharashtra, and it ended with ‘zero’ observations.
The US Food and Drug Administration (USFDA) had conducted a remote and virtual bio-analytical inspection of the company’s Bioequivalence Center located at Taloja, Maharashtra from 26th to 28th July, 2021, Alkem Laboratories said in a regulatory filing.
At the end of the inspection, no form 483 was issued, the company added.
A form 483 is issued by the USFDA to notify a company’s management of any objectionable condition at its manufacturing facility. The form is issued after completing the inspection.
Granules Pharma clears USFDA audit
Zydus Cadila gets USFDA nod for Ibrutinib tablets
Lupin gets USFDA nod for generic Antifungal drug
Unichem gets tentative USFDA nod for drug to treat Diabetes
Alembic gets USFDA final nod for Erlotinib Tablets
Alembic gets USFDA nod for drug for the treatment of Depression
India and Pharmacy Education: Chapter: 2
88% price reduction of 5 Medical Devices reported: NPPA
FDA approves 7 more units to manufacture Remdesivir
Pharmexcil seeks list of products from Pharma Exporters
NPPA fixes ceiling prices of 355 Medicines and 882 Formulations
CDSCO classifies 208 Medical Devices in various categories
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
